Annual report [Section 13 and 15(d), not S-K Item 405]

Segments (Tables)

v3.26.1
Segments (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Reportable Segment Profit and Loss, Including Significant Expense Categories

The following table presents reportable segment profit and loss, including significant expense categories, attributable to the Company’s reportable segment for the periods presented:

 Schedule of Reportable Segment Profit and Loss, Including Significant Expense Categories

    2025     2024  
    For The Years  
    Ended December 31,  
    2025     2024  
             
Revenue, net:   $ 38,728     $ 46,926  
Less:                
Cost of revenue:                
Fixed     6,810       6,790  
Variable     7,788       10,211  
Sales and marketing     9,924       11,655  
Research and development     642       676  
General and administrative     9,480       9,486  
Interest & other expense, net     310       1,158  
(Benefit) provision for income taxes     (21,210 )     4  
Segment net income     24,984       6,946  
Reconciliation of profit or loss:                
Loss on discontinued operations     (409 )     (244 )
Consolidated net income   $ 24,575     $ 6,702  
Schedule of Reconciliation of Adjusted EBITDA

    2025     2024  
    Years Ended  
    December 31,  
    2025     2024  
             
Income from continuing operations (GAAP Basis)   $ 24,984     $ 6,946  
Depreciation and amortization     425       300  
Stock-based compensation     35       291  
Severance & related expense     692       -  
Asset impairment - lab supplies     198       -  
Tax (benefit) expense     (21,210 )     4  
Interest accretion expense     -       34  
Note payable interest     168       625  
Other expense/income, net     32       (48 )
Change in fair value of note payable     110       547  
Adjusted EBITDA   $ 5,434     $ 8,699